After six months of infection, patients with severe COVID-19 presented reduced PDGF (Figure 4B) and TGF-β (Figure 4J), as compared with controls, whereas the levels of FGF-1 were not different (Figure 4F). This evidence concerns the gene TGFB1 and COVID-19.